Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain.
Suzetrigine, now marketed as Journavx, is not the first sodium-channel-targeting drug for pain management. Compounds such as procaine (Novocain) have provided reliable anaesthesia for more than a ...
It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the medication intended to improve their life. It’s left both healthcare ...